- Home
- ATXG vs RDHL Comparison
ATXG vs RDHL Comparison
Compare ATXG & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXG
- RDHL
- Stock Information
- Founded
- ATXG 2014
- RDHL 2009
- Country
- ATXG China
- RDHL Israel
- Employees
- ATXG N/A
- RDHL N/A
- Industry
- ATXG Professional Services
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- ATXG Consumer Discretionary
- RDHL Health Care
- Exchange
- ATXG Nasdaq
- RDHL Nasdaq
- Market Cap
- ATXG 3.8M
- RDHL 3.9M
- IPO Year
- ATXG N/A
- RDHL N/A
- Fundamental
- Price
- ATXG $0.48
- RDHL $1.36
- Analyst Decision
- ATXG
- RDHL
- Analyst Count
- ATXG 0
- RDHL 0
- Target Price
- ATXG N/A
- RDHL N/A
- AVG Volume (30 Days)
- ATXG 243.5K
- RDHL 1.4M
- Earning Date
- ATXG 08-14-2025
- RDHL 08-28-2025
- Dividend Yield
- ATXG N/A
- RDHL N/A
- EPS Growth
- ATXG N/A
- RDHL N/A
- EPS
- ATXG N/A
- RDHL N/A
- Revenue
- ATXG $4,310,835.00
- RDHL $8,042,999.00
- Revenue This Year
- ATXG N/A
- RDHL $381.91
- Revenue Next Year
- ATXG N/A
- RDHL N/A
- P/E Ratio
- ATXG N/A
- RDHL N/A
- Revenue Growth
- ATXG N/A
- RDHL 23.17
- 52 Week Low
- ATXG $0.36
- RDHL $1.06
- 52 Week High
- ATXG $1.86
- RDHL $12.50
- Technical
- Relative Strength Index (RSI)
- ATXG 42.00
- RDHL 41.90
- Support Level
- ATXG $0.43
- RDHL $1.06
- Resistance Level
- ATXG $0.48
- RDHL $1.43
- Average True Range (ATR)
- ATXG 0.05
- RDHL 0.11
- MACD
- ATXG 0.00
- RDHL 0.02
- Stochastic Oscillator
- ATXG 55.34
- RDHL 45.45
About ATXG Addentax Group Corp.
Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.